Increasing potency and price of cannabis in Europe, 2006–16
Abstract Aims: To quantify changes in (i) potency (concentration of Δ9‐tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value…
Abstract Aims: To quantify changes in (i) potency (concentration of Δ9‐tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value…
Abstract The main active ingredient in cannabis, delta-9-tetrahydrocannabinol (THC), can acutely induce psychotic symptoms and impair episodic and working memory.…
Abstract Background: Changes in cannabis regulation globally make it increasingly important to determine what predicts an individual’s risk of experiencing…
Abstract Background and Aims: Cannabidiol (CBD), a non‐intoxicating cannabinoid found in cannabis, may be a promising novel smoking cessation treatment…
Abstract Introduction: Major gaps exist in the measurement of cannabis exposure. The accuracy of self-reported cannabis and tobacco dose per…
Abstract Rationale: Cannabis and tobacco are often smoked simultaneously in joints, and this practice may increase the risks of developing…
Abstract Acute administration of the primary psychoactive constituent of cannabis, Δ-9-tetrahydrocannabinol (THC), impairs human facial affect recognition, implicating the endocannabinoid…
Abstract ► We study the acute effects of cannabis on divergent thinking and schizotypy. ► Quartile splits compared those lowest…